Poland· PL-100245804

Zoely

A nomegestrol und estradiol product containing nomegestroli acetas + estradiolum, registered in Poland by Theramex Ireland Limited. The same ATC class is registered in 10 of our 19 countries.

ATC G03AA14

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedZoelyATCG03AA14REGISTER NO.PL-100245804PACKS LISTED8CHECKEDSeptember 27, 2026

Where it is registered

Nomegestrol und estradiol is registered in 10 of 19 countries.

Countries holding a registration under ATC G03AA14 (nomegestrol und estradiol), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Nomegestrol und estradiol · ATC G03AA14

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Nomegestroli acetas + Estradiolum
Manufacturer
Theramex Ireland Limited
Country
Poland (PL)
ATC code
G03AA14
ATC class
Nomegestrol und Estradiol
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 8

  • gtin
    05909990861729
  • gtin
    05909990861736
  • gtin
    05909991001605
  • gtin
    05909991001629
  • gtin
    05060632507044
  • gtin
    05060632507174
  • gtin
    05060632509970
  • gtin
    5903792743825

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

29 interactions on record for nomegestrol und estradiol.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Nomegestrol und estradiol · interactions on record

29 records

29 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/47b95ad8-1c71-4e87-a5ff-29452fdaab2b
GET /v1/drugs/47b95ad8-1c71-4e87-a5ff-29452fdaab2b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "2,5 mg + 1,5 mg",
  "packaging": "05909990861729 ¦ Rp ¦ Skasowane ¦ EU/1/11/690/001 ¦ 65961\n28 tabl.\n05909990861736 ¦ Rp ¦ Skasowane ¦ EU/1/11/690/002 ¦ 65962\n84 tabl.\n05909991001605 ¦ Rp ¦ EU/1/11/690/003 ¦ 78681\n168 tabl.\n05909991001629 ¦ Rp ¦ EU/1/11/690/004 ¦ 78682\n364 tabl.\n05060632507044 ¦ Rp ¦ Skasowane ¦ EU/1/11/690/001 ¦ 134481\n28 tabl.\n¦ UR/Z/4c/314/25 - 05060632507044\n05060632507174 ¦ Rp ¦ EU/1/11/690/002 ¦ 134482\n84 tabl.\n¦ UR/Z/4c/315/25 - 05060632507174\n5903792743825 ¦ Rp ¦ EU/1/11/690/001 ¦ InPharm Sp. z o.o. ¦ 165864\n28 tabl.\n05060632509970 ¦ Rp ¦ EU/1/11/690/001 ¦ 166836\n28 tabl.",
  "substance": "Nomegestroli acetas 2.5 mg + Estradiolum 1.5 mg",
  "common_name": "Nomegestroli acetas + Estradiolum",
  "pl_product_id": "100245804",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}

See everything about nomegestrol und estradiol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.